These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34271781)

  • 41. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome.
    Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI;
    Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for germline mutations in mismatch repair genes in patients with Lynch syndrome by next generation sequencing.
    Soares BL; Brant AC; Gomes R; Pastor T; Schneider NB; Ribeiro-Dos-Santos Â; de Assumpção PP; Achatz MIW; Ashton-Prolla P; Moreira MAM
    Fam Cancer; 2018 Jul; 17(3):387-394. PubMed ID: 28932927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Universal screening to identify Lynch syndrome: two years of experience in a Northern Italian Center.
    Chiaravalli AM; Carnevali I; Sahnane N; Leoni E; Furlan D; Berselli M; Sessa F; Tibiletti MG
    Eur J Cancer Prev; 2020 Jul; 29(4):281-288. PubMed ID: 31609810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
    Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
    JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome.
    Hansen MF; Johansen J; Sylvander AE; Bjørnevoll I; Talseth-Palmer BA; Lavik LAS; Xavier A; Engebretsen LF; Scott RJ; Drabløs F; Sjursen W
    Clin Genet; 2017 Oct; 92(4):405-414. PubMed ID: 28195393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of Lynch syndrome risk variants in the Romanian population.
    Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Benonisdottir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Mates IN; Dobra M; Nicolae C; Kristjansdottir S; Jonasson JG; Manolescu A; Arnadottir G; Jensson B; Jonasdottir A; Sigurdsson A; le Roux L; Johannsdottir H; Rafnar T; Halldorsson BV; Jinga V; Stefansson K
    J Cell Mol Med; 2018 Dec; 22(12):6068-6076. PubMed ID: 30324682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability.
    Kets CM; van Krieken JH; Hebeda KM; Wezenberg SJ; Goossens M; Brunner HG; Ligtenberg MJ; Hoogerbrugge N
    Br J Cancer; 2006 Dec; 95(12):1678-82. PubMed ID: 17117178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer (HNPCC).
    Nallamilli BRR; Hegde M
    Curr Protoc Hum Genet; 2017 Jul; 94():10.12.1-10.12.23. PubMed ID: 28696559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch Syndrome.
    Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Wang CY; You JF; Hsiung CA; Yeh CC
    PLoS One; 2015; 10(6):e0130018. PubMed ID: 26053027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients.
    Jóri B; Kamps R; Xanthoulea S; Delvoux B; Blok MJ; Van de Vijver KK; de Koning B; Oei FT; Tops CM; Speel EJ; Kruitwagen RF; Gomez-Garcia EB; Romano A
    Oncotarget; 2015 Dec; 6(38):41108-22. PubMed ID: 26517685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
    Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
    N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
    Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
    Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD).
    Ramchander NC; Ryan NA; Crosbie EJ; Evans DG
    BMC Med Genet; 2017 Apr; 18(1):40. PubMed ID: 28381238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
    Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
    Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathology and genetics of hereditary colorectal cancer.
    Ma H; Brosens LAA; Offerhaus GJA; Giardiello FM; de Leng WWJ; Montgomery EA
    Pathology; 2018 Jan; 50(1):49-59. PubMed ID: 29169633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer.
    Mork ME; You YN; Ying J; Bannon SA; Lynch PM; Rodriguez-Bigas MA; Vilar E
    J Clin Oncol; 2015 Nov; 33(31):3544-9. PubMed ID: 26195711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
    Casey MJ; Bewtra C; Lynch HT; Snyder C; Stacy M; Watson P
    Fam Cancer; 2013 Dec; 12(4):719-40. PubMed ID: 23666231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
    Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD;
    Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree.
    Wagner A; Hendriks Y; Meijers-Heijboer EJ; de Leeuw WJ; Morreau H; Hofstra R; Tops C; Bik E; Bröcker-Vriends AH; van Der Meer C; Lindhout D; Vasen HF; Breuning MH; Cornelisse CJ; van Krimpen C; Niermeijer MF; Zwinderman AH; Wijnen J; Fodde R
    J Med Genet; 2001 May; 38(5):318-22. PubMed ID: 11333868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic predisposition to colorectal cancer: Implications for treatment and prevention.
    Stoffel EM; Yurgelun MB
    Semin Oncol; 2016 Oct; 43(5):536-542. PubMed ID: 27899184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.